|
BOD1L expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.075500E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.561810E-01 |
| Normal-vs-Stage2 |
1.930980E-01 |
| Normal-vs-Stage3 |
3.19940000048646E-07 |
| Normal-vs-Stage4 |
1.52297999999051E-05 |
| Stage1-vs-Stage2 |
7.541800E-01 |
| Stage1-vs-Stage3 |
3.70270000005224E-06 |
| Stage1-vs-Stage4 |
1.410680E-04 |
| Stage2-vs-Stage3 |
2.416100E-02 |
| Stage2-vs-Stage4 |
3.815600E-02 |
| Stage3-vs-Stage4 |
8.726800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.423600E-03 |
| Normal-vs-AfricanAmerican |
5.506500E-02 |
| Normal-vs-Asian |
7.996800E-01 |
| Caucasian-vs-AfricanAmerican |
8.280400E-01 |
| Caucasian-vs-Asian |
4.092800E-01 |
| AfricanAmerican-vs-Asian |
5.456200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.357700E-03 |
| Normal-vs-Female |
1.561820E-02 |
| Male-vs-Female |
3.663600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.988200E-02 |
| Normal-vs-Age(41-60Yrs) |
5.623900E-02 |
| Normal-vs-Age(61-80Yrs) |
6.847600E-04 |
| Normal-vs-Age(81-100Yrs) |
5.642200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.941400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.723200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.126600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.013900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.062400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.451950E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.877900E-02 |
| Normal-vs-Grade 2 |
1.448790E-01 |
| Normal-vs-Grade 3 |
1.85991999999136E-05 |
| Normal-vs-Grade 4 |
1.65691999999273E-05 |
| Grade 1-vs-Grade 2 |
3.600300E-03 |
| Grade 1-vs-Grade 3 |
1.85109999994992E-06 |
| Grade 1-vs-Grade 4 |
1.36279999995992E-06 |
| Grade 2-vs-Grade 3 |
3.553700E-04 |
| Grade 2-vs-Grade 4 |
2.605800E-04 |
| Grade 3-vs-Grade 4 |
3.473600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.795400E-01 |
| Normal-vs-ccB subtype |
5.423600E-04 |
| ccA subtype-vs-ccB subtype |
2.404200E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.803500E-03 |
| Normal-vs-N1 |
6.473800E-02 |
| N0-vs-N1 |
7.385600E-01 |
|
|
